Stams, et.al., showed that in ALL patients with TEL/AML1 fusion, despite that fact that a consistent increase in ASNS mRNA following L-asparaginase treatment was observed, no correlation was found in overall therapeutic responses [57]. The gene discussed is ASNS; the disease is acute lymphoblastic leukemia.